Total Funding
34
Total FundingPost-IPO Equity raised
Growth Score
pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
126769
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
Acquired by 
Astellas Pharma
Samir Patel: Co-founder and President, Vice Chairman, Board of Directors
Henry Simon: Director
Astellas Pharma
About the Company
IVERIC bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The Company is currently developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited
retinal diseases.
